A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
about
Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41Antibody vs. HIV in a clash of evolutionary titansComprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesPolyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individualsCellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120Current Advances in Virus-Like Particles as a Vaccination Approach against HIV InfectionStructural insights on the role of antibodies in HIV-1 vaccine and therapyA Blueprint for HIV Vaccine DiscoveryHIV-1 neutralizing antibodies: understanding nature's pathwaysAntibodies in HIV-1 vaccine development and therapyHIV-1 antibodies from infection and vaccination: insights for guiding vaccine designCatching HIV 'in the act' with 3D electron microscopyA saposin-lipoprotein nanoparticle system for membrane proteins.Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesA Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing AntibodiesCrystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design ImplicationsInteractions between Lipids and Human Anti-HIV Antibody 4E10 Can Be Reduced without Ablating Neutralizing ActivityCrystal Structure of the Neutralizing Llama VHH D7 and Its Mode of HIV-1 gp120 InteractionStructural Characterization of HIV gp41 with the Membrane-proximal External RegionDistinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodiesSequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 BindingFocused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep SequencingBroad and potent neutralization of HIV-1 by a gp41-specific human antibodyStructure-Based Design of a Protein Immunogen that Displays an HIV-1 gp41 Neutralizing EpitopeA gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen RecognitionSomatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 NeutralizationAutoreactivity and Exceptional CDR Plasticity (but Not Unusual Polyspecificity) Hinder Elicitation of the Anti-HIV Antibody 4E10Structural Basis for HIV-1 Neutralization by 2F5-Like Antibodies m66 and m66.6Structure and Immunogenicity of a Peptide Vaccine, Including the Complete HIV-1 gp41 2F5 EpitopeStructure of an HIV-1-neutralizing antibody target, the lipid-bound gp41 envelope membrane proximal region trimerStructural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.Global shape and ligand binding efficiency of the HIV-1-neutralizing antibodies differ from those of antibodies that cannot neutralize HIV-1The good and evil of complement activation in HIV-1 infectionPeptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infectionDeterminants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype BNeutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from IndiaRecognition of membrane-bound fusion-peptide/MPER complexes by the HIV-1 neutralizing 2F5 antibody: implications for anti-2F5 immunogenicityAllosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivityIDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platform
P2860
Q24533287-4ED04C4B-CCEA-4902-AF96-2D19AA3130F4Q24536059-CFF82AC4-42C4-44E9-807B-1118F403A6C9Q24561905-CF66E75B-F911-4B90-A590-88619115968CQ24635002-2FA7E185-8CA4-4854-A8BF-9A06816925A5Q24806134-D90CAF93-ED6E-4B78-B5DA-F4901FB7C1B2Q26775082-5BC0C13D-600F-4030-B3F8-990A4528283DQ26829461-09EC9F57-3E81-46EC-A090-4D28C8CAC0FEQ26829865-D86B920A-27B9-48F4-8C76-B554AB1D2671Q27000480-891A5DBE-5298-4872-99B8-E1A65FB424FAQ27011574-7D3C34DC-0295-478C-AF4A-C89116229044Q27022055-7E2EE86F-60FF-4CBA-B70D-DAB57437C961Q27026806-CFFFB08C-717B-4C27-BE27-538F80D411F1Q27313390-B1CD4551-A3F4-4E6D-AB55-B7FD1C1F4D21Q27489000-F537ABBA-E75A-45A9-8056-22D0ABC8A0A0Q27655865-0CC089FB-C3FB-44BA-A056-A842C6E8DBC5Q27657377-28FBF749-7C2A-4D46-8F49-AD2F416CA807Q27658138-B6F564C9-0A38-45B9-AC66-9A207DE84F2CQ27661588-D26E449E-9058-40D5-9334-DD3B31854A2AQ27662117-413ADB3D-5D24-44E0-95FE-A903E504D98CQ27665884-405B19CD-2D57-49D4-B2A5-0CE7E8FFF969Q27670829-3D05E188-1993-487D-926D-A71302E634B4Q27671696-60A6CDE6-4241-4CE4-813E-FEC7C2AC9136Q27675131-C1E77EC8-7DDA-4943-A148-00CD4BB82C69Q27675260-DE137CAC-AE2E-482A-9F20-10CFED81C7D1Q27676864-C9ACD7F4-D848-48A7-AB3B-1498BC0C2F79Q27677117-67727455-5B56-4A26-B039-A9541EB36C64Q27680125-BC843EA4-36B0-40AA-B7F5-4A6312637F2CQ27680872-A6ED2F5E-2E79-4A59-8FBE-58DE81B85168Q27681352-B0279212-E6BB-4F79-92F3-088A9F80DE1AQ27681501-44F6138E-6A8E-4D10-B65B-05A3D25B45D9Q27683553-AA5ABE3F-DE4B-41A3-AD47-E41A624852FEQ28250040-EE68D151-1A81-4B5A-A03A-C9C4B11EAF3AQ28275986-F6900909-A523-4681-AC38-20718B56D959Q28369033-7FB9FC95-D4F0-495B-B7A6-9E75B1AA4223Q28379310-2AC5DF33-B428-4DA2-9985-76F1B1989F95Q28469023-8FD96E4A-26E4-4015-A1E5-04CB8882A212Q28483205-43A3917C-A96A-4ED4-B9A8-CF15965E825EQ28484544-46D5181A-4011-4DD2-A55C-8F9E655674ECQ28485983-24963B76-FB62-4D08-ADA2-6887786FCAC5Q28543211-FC7DE1E6-E274-4EF3-A0ED-6B42A35D6075
P2860
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
description
1993 nî lūn-bûn
@nan
1993 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
@ast
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
@en
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
@nl
type
label
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
@ast
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
@en
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
@nl
prefLabel
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
@ast
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
@en
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
@nl
P2093
P2860
P1433
P1476
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
@en
P2093
Katinger H
Purtscher M
P2860
P304
P407
P577
1993-11-01T00:00:00Z